White blood cell counts and thrombosis in polycythemia vera: A subanalysis of the CYTO-PV study

Blood

Volumn 126, Issue 4, 2015, Pages 560-561

  Barbui, Tiziano ^a   Masciulli, Arianna ^a   Marfisi, Maria Rosa ^a   Tognoni, Giovanni ^b   Finazzi, Guido ^a   Rambaldi, Alessandro ^a   Vannucchi, Alessandro ^c  

^a PAPA GIOVANNI XXIII HOSPITAL   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ARTERY THROMBOSIS; ARTICLE; CYTOREDUCTIVE SURGERY; DISEASE ASSOCIATION; FOLLOW UP; GENE MUTATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; INCIDENCE; LEUKOCYTE; LEUKOCYTE COUNT; MYELOPROLIFERATIVE NEOPLASM; POLYCYTHEMIA VERA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RISK FACTOR; THROMBOCYTE COUNT; THROMBOCYTHEMIA; TREATMENT RESPONSE; VEIN THROMBOSIS; WORLD HEALTH ORGANIZATION; BLOOD; BLOOD CELL COUNT; COMPLICATION; PATHOLOGY; PHLEBOTOMY; PROGNOSIS; THROMBOSIS;

BLOOD CELL COUNT; CYTOREDUCTION SURGICAL PROCEDURES; HUMANS; PHLEBOTOMY; POLYCYTHEMIA VERA; PROGNOSIS; THROMBOSIS;

EID: 84938092170     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2015-04-638593     Document Type: Article

References (8)

1. Barbui T, Finazzi G, Falanga A. Myeloproliferative neoplasms and thrombosis. Blood. 2013;122(13):2176-2184.
2. Landolfi R, Di Gennaro L, Barbui T, et al European Collaboration on Low-Dose Aspirin in Polycythemia Vera (ECLAP). Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera. Blood. 2007;109(6):2446-2452.
3. Marchioli R, Finazzi G, Specchia G, et al CYTO-PV Collaborative Group. Cardiovascular events and intensity of treatment in polycythemia vera. N Engl J Med. 2013;368(1):22-33.
4. Carobbio A, Finazzi G, Guerini V, et al. Leukocytosis is a risk factor for thrombosis in essential thrombocythemia: interaction with treatment, standard risk factors, and Jak2 mutation status. Blood. 2007;109(6): 2310-2313.
5. Campbell PJ, MacLean C, Beer PA, et al. Correlation of blood counts with vascular complications in essential thrombocythemia: analysis of the prospective PT1 cohort. Blood. 2012;120(7):1409-1411.
6. Carobbio A, Antonioli E, Guglielmelli P, et al. Leukocytosis and risk stratification assessment in essential thrombocythemia. JClin Oncol. 2008;26(16):2732-2736.
7. Barbui T, Carobbio A, Cervantes F, et al. Thrombosis in primary myelofibrosis: incidence and risk factors. Blood. 2010;115(4):778-782.
8. Buxhofer-Ausch V, Gisslinger H, Thiele J, et al. Leukocytosis as an important risk factor for arterial thrombosis in WHO-defined early/prefibrotic myelofibrosis: an international study of 264 patients. Am J Hematol. 2012;87(7):669-672.